Le Lézard
Classified in: Health, Science and technology
Subjects: TDS, FVT

Kodiak Sciences to Present at the Jefferies Global Healthcare Conference


PALO ALTO, Calif., May 27, 2022 Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that management will present at the Jefferies Global Healthcare Conference in New York, NY on Thursday, June 9, 2022, at 11:30 a.m. Pacific Time (2:30 p.m. Eastern Time).

A live webcast of the presentation will be available on the "Events and Presentations" section of Kodiak's website at http://ir.kodiak.com/ and will remain available for replay for a limited time following the event.

About Kodiak Sciences Inc.

Kodiak (Nasdaq: KOD) is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. Founded in 2009, we are focused on bringing new science to the design and manufacture of next generation retinal medicines to prevent and treat the leading causes of blindness globally. Our ABC Platformtm uses molecular engineering to merge the fields of antibody-based and chemistry-based therapies and is at the core of Kodiak's discovery engine. Kodiak's lead product candidate, KSI-301, is a novel anti-VEGF antibody biopolymer conjugate being developed for the treatment of retinal vascular diseases including wet age-related macular degeneration, the leading cause of blindness in elderly patients in the developed world, and diabetic eye diseases, the leading cause of blindness in working-age patients in the developed world. Kodiak has leveraged its ABC Platform to build a pipeline of product candidates in various stages of development. KSI-501 is our dual inhibitor antibody biopolymer conjugate targeting both VEGF (VEGF-trap) and IL-6 (anti-IL-6 antibody) for the treatment of retinal diseases. We are expanding our early research pipeline to include ABC Platform based triplet inhibitors for multifactorial retinal diseases such as dry AMD and glaucoma. Kodiak is based in Palo Alto, CA. For more information, please visit www.kodiak.com.

SOURCE Kodiak Sciences Inc.


These press releases may also interest you

at 13:12
Radians quarterly grassroots Tickets for Charity program empowers Midsouth nonprofits JIFF and The ARC Northwest Mississippi
Empowered by employee donations and matched by management contributions, Radians® quarterly Tickets for Charity (TFC) program champions local Memphis and Midsouth charities, offering crucial support for sustaining daily operations and expanding their...

at 13:07
Multi-talented Emmy® Award-Winning Host & Actress Tamera Mowry-Housley Set to Receive Trailblazer Award at A Pink Pump Affair
Multi-award-winning Civil Rights Attorney and Child Advocate, Areva Martin, in collaboration with the Special Needs Network (SNN), has revealed the distinguished honorees for the 16th Annual A Pink Pump Affair. This noteworthy charity event is...

at 13:05
Convergent Dental's "Solea User Group Meeting" Rebranded to "Solea Summit"
Convergent Dental, the power behind the Solea® All-Tissue Dental Laser, proudly announces the rebranding of its annual customer event from the "Solea User Group Meeting" to the "Solea Summit." This update reflects the evolution of the event into the...

at 13:00
Laniado Hospital Kicks Off Major Campaign For Building New Rocket-Proof Emergency Building In Netanya
The Laniado Hospital in Netanya, Israel, is embarking on a crucial initiative to construct the country's first fully sheltered emergency care building. With the support of the Laniado Development Fund, this endeavor aims to enhance public healthcare...

at 13:00
Ocenture Unveils Joint Partnership with Iron Remedy MD, Founded by Iconic Boxing Legend, Entertainer and Entrepreneur Mike Tyson.
Ocenture, a prominent player in Telemedicine and private label development for three decades, proudly announces a partnership with Iron Remedy MD, a concierge healthcare company founded by Ocenture and iconic boxing legend, entertainer, and serial...

at 12:52
Tampa General Hospital, Manatee County and ArcherFRS Introduce First-In-The-Nation Program to Deliver Life-Saving Emergency Response Equipment Via Drone Delivery
As part of Tampa General Hospital's (TGH) commitment to transforming health care through innovation, the academic health system collaborated with Manatee County and Archer First Response Systems (ArcherFRS) to accelerate response times to...

More news about Health...


News published on and distributed by: